The central hypothesis of excitotoxicity is that excessive stimulation of neuronal NMDA-sensitive glutamate receptors is harmful to neurons and contributes to a variety of neurological disorders. Glial cells have been proposed to participate in excitotoxic neuronal loss, but their precise role is defined poorly. In this in vivo study, we show that NMDA induces profound nuclear factor B (NF-B) activation in Müller glia but not in retinal neurons. Intriguingly, NMDA-induced death of retinal neurons is effectively blocked by inhibitors of NF-B activity. We demonstrate that tumor necrosis factor ␣ (TNF␣) protein produced in Müller glial cells via an NMDA-induced NF-B-dependent pathway plays a crucial role in excitotoxic loss of retinal neurons. This cell loss occurs mainly through a TNF␣dependent increase in Ca 2ϩ -permeable AMPA receptors on susceptible neurons. Thus, our data reveal a novel non-cell-autonomous mechanism by which glial cells can profoundly exacerbate neuronal death following excitotoxic injury.
Introduction
Glutamate is the predominant excitatory neurotransmitter in many regions of the CNS. Elevation of endogenous glutamate and activation of glutamate receptors contribute to a variety of acute and chronic neurological disorders, including hypoxicischemic brain injury (stroke), trauma, seizures, and various forms of dementia and neurodegeneration (Kalia et al., 2008) . In the retina, excess glutamate has been proposed to underlie common neurodegenerative disorders, including glaucoma and retinal artery occlusion (Hare et al., 2001 (Hare et al., , 2004 Casson, 2006; Seki and Lipton, 2008) . The central hypothesis for excitotoxic injury is that excess glutamate binds to cell surface NMDA receptors on neurons, triggers massive Ca 2ϩ influx, and activates proapoptotic signaling cascades. However, NMDA antagonists have consistently failed in clinical trials (Lee et al., 1999; Ikonomidou and Turski, 2002; Kemp and McKernan, 2002) , suggesting that other mechanisms contribute to the devastating excitotoxic damage that occurs in vivo.
Neighboring non-neuronal cells may facilitate neuronal damage after excitotoxic injury. For example, activated microglia and astrocytes produce proinflammatory cytokines after excitotoxic injury (Wood, 1995; Barone and Feuerstein, 1999; Jeon et al., 2008; Vogt et al., 2008) . Tissue plasminogen activator derived from microglia promotes excitotoxin-induced neuronal death in the hippocampus (Tsirka et al., 1995) , whereas inhibition of microglial activation and proliferation has been shown to reduce excitotoxic injury (Tikka et al., 2001) . Collectively, these data support a model in which excitotoxic brain damage activates glial cells, which then enhance neuronal death. However, the molecular mechanisms by which glial cells regulate excitotoxic loss of neurons have not yet been defined. A primary aim of this study was to investigate whether non-neuronal cells play a role in excitotoxic injury in the adult retina and, if so, to define the molecular pathways by which they influence neuronal death in vivo.
A potential effector of injury in the CNS is the nuclear factor B (NF-B). In non-neuronal cells, NF-B activates transcription of antiapoptotic genes and production of cytokines and chemokines that mediate inflammation (Hoffmann and Baltimore, 2006) . NF-B also plays important roles in the nervous system, both promoting neuronal survival and facilitating synaptic function (Mattson and Camandola, 2001; Meffert and Baltimore, 2005) . The role of NF-B in neuropathological settings, however, has been controversial. Several studies have indicated that NF-B is neuroprotective after injury (Maggirwar et al., 1998; Hamanoue et al., 1999; Bhakar et al., 2002) , whereas others have shown that NF-B activation facilitates neuronal damage (Schneider et al., 1999; Schwaninger et al., 2006) .
In this study, we report that the extensive death of retinal neurons induced by NMDA is effectively blocked with pharmacological inhibitors of NF-B activity. Using a transgenic NF-B reporter mouse, we unequivocally identify the cellular site of NMDA-induced NF-B activation as Müller glial cells. Further-more, we demonstrate that NF-B-dependent tumor necrosis factor ␣ (TNF␣) production by Müller cells promotes retinal ganglion cell death. Finally, we show that Müller cell-derived TNF␣ leads to neuronal loss by increasing cell surface expression of Ca 2ϩ -permeable AMPA receptors (AMPARs). Our data reveal a novel non-cell-autonomous pathway by which retinal glia can exacerbate neuronal death following excitotoxic injury.
Materials and Methods

Experimental animals
Experimental procedures were carried out on C57BL/6 transgenic or wild-type littermate control mice in accordance with the policies on the Use of Animals in Neuroscience Research and the Canadian Council on Animal Care guidelines (Olfert et al., 1993) . The NF-B reporter mice contain an NF-B-responsive minigene composed of three tandem HIVderived B binding repeats placed upstream of a minimal SV40 promoter and drive expression of an Escherichia coli ␤-galactosidase (␤-gal) gene tagged with a nuclear localization sequence (Bhakar et al., 2002) . TNF␣ knock-out mice were kindly provided by Dr. D. Stellwagen (Montreal General Hospital, McGill University, Montreal, QC, Canada). The num-ber of animals used in each experiment (n) is shown on each graph and/or in the figure legend.
Intraocular injections
NMDA (20 mM; Sigma) was injected into the vitreous chamber of the left eye using a 10 l Hamilton syringe adapted with a 32 gauge glass microneedle (total volume, 2 l). The vitreous fluid in adult mice is estimated to range from 5 to 20 l (Remtulla and Hallett, 1985; Sharma et al., 2005; Yu and Cringle, 2006) ; therefore, the concentration of NMDA that reaches retinal ganglion cells is 2-8 mM. This amount of NMDA allows us to compare our results with previous studies using similar NMDA concentrations (Shimazawa et al., 2005; Ito et al., 2008; Nakazawa et al., 2008) .
NMDA was injected alone or in combination with cell-permeable recombinant SN50 peptide (100 g/ml; Biomol), SN50M (100 g/ml; Biomol), PS1145 (500 M; a kind gift from Millennium Pharmaceuticals), MK-801 (1 mM; Sigma), Etanercept (Enbril; 25 g/l; Immunex), z-IETD-fmk (50 M; Biovision), GYKI 52466 (500 M; Tocris), or IEM 13460 (500 M; Sigma). Eyes injected with vehicle (PBS), control Fc, or noninjected intact eyes served as controls. Intraocular injections were performed under general anesthesia (2% isoflurane/oxygen mixture, 0.8 L/min). The needle tip was inserted into the superior hemisphere of the eye, at a 45°a ngle through the sclera into the vitreous body. This route of administration avoided retinal detachment or injury to eye structures, including the iris and lens, which release factors that induce neuronal survival (Mansour-Robaey et al., 1994; Leon et al., 2000; Fischer et al., 2001) . Surgical glue (Indermill; Tyco Health Care) was used to seal the injection site.
␤-gal detection
Mice were perfused transcardially with 0.8% glutaraldehyde, and the eyes were immediately dissected out. Tissue was incubated overnight at 37°C in staining solution containing 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, and 1 mg/ml 5-bromo-4-chloro-3indolyl-␤-galactopyranoside (Invitrogen). Tissue was embedded in optimal cutting temperature (OCT) compound (Tissue-Tek; Miles), and retinal cryosections (16 m) were collected onto gelatin-coated slides and examined under light microscopy.
Retinal immunohistochemistry
Mice were perfused with 4% paraformaldehyde, and retinal sections were prepared as above. Tissue sections were first incubated in 3% BSA and 0.3% Triton X-100 (Sigma) to block nonspecific binding, then incubated with primary antibody (Ab) (see list below) overnight at 4°C, followed by incubation with secondary Ab at room temperature. Slides were mounted with SlowFade (Invitrogen) and visualized on a Zeiss Axioskop 2 Plus microscope. Primary Abs used were ␤-gal (6.6 g/ml; Millipore Bioscience Research Reagents), cellular retinaldehyde-binding protein (1:1000; a gift from J. C. Saari, University of Washington, Seattle, WA), protein kinase C (5 g/ml; BD Biosciences), calretinin (2 g/ml; Millipore Bioscience Research Reagents), glial fibrillary acidic protein (2.5 g/ml; Millipore Bioscience Research Reagents), and macrophage/ monocytes (MAC-1; 1:2; a gift from S. David, McGill University, Montreal, QC, Canada), and TNF␣ (0.4 g/ml; Millipore Bioscience Research Reagents). The secondary Abs used were sheep anti-mouse IgG (1 g/ml; FITC conjugate; Sigma) or anti-rabbit IgG (1 g/ml; Cy3; Jackson Im-munoResearch Laboratories). 
Immunoblot analysis
Retinas were homogenized in lysis buffer and centrifuged at 10,000 rpm for 5 min, and supernatants were collected and analyzed by SDS polyacrylamide gels and immunoblotting. Membranes were incubated with TNF␣ Ab (0.2 g/ml; Millipore Bioscience Research Reagents) or ␤-actin (0.5 g/ml; Sigma), washed in Tris-buffered saline-Tween 20, and then incubated with peroxidase-linked secondary Ab (0.5 g/ml; GE Healthcare). Protein signals were detected using a chemiluminescence reagent (ECL; GE Healthcare) followed by exposure of blots to X-OMAT (Kodak) imaging film.
Cell survival assays and quantification
Terminal dUTP nick end labeling. The terminal dUTP nick end labeling (TUNEL) assay (Gavrieli et al., 1992) was performed using the In Situ Apoptosis Detection Kit (Millipore Bioscience Research Reagents) on retinal cryosections following the manufacturer's instructions. TUNELpositive cells in the entire retinal section were counted on 16 sections per eye.
Retrograde labeling. Fluorogold (2%; Fluorochrome) in 0.9% NaCl was applied to the superior colliculus as described previously (Sapieha et al., 2005) . The maximum number of retinal ganglion cells is observed after 7 d of Fluorogold application, and it is stable for several weeks thereafter (Berkelaar et al., 1994; Mansour-Robaey et al., 1994; Peinado-Ramó n et al., 1996; Cheng et al., 2002) . Therefore, procedures were performed 1 week after Fluorogold application. Mice were perfused with 4% paraformaldehyde; the eyes were dissected and flat-mounted vitreal side up on glass sides. Fluorogold-positive retinal ganglion cells were counted in 12 retinal zones: three areas in each eye quadrant located at 0.5, 1.0, and 1.5 mm from the optic nerve head were examined (Sapieha et al., 2005) , corresponding to a total area of 0.5 mm 2 .
Identification of Ca 2ϩ -permeable AMPARs
Ca 2ϩ -permeable AMPARs were identified using the Co 2ϩ staining technique (Osswald et al., 2007) . Retinas were dissected, cut in small pieces, and incubated for 30 min in oxygenated assay buffer (5 mM KCl, 2 mM MgCl, 12 mM glucose, 20 mM bicarbonate, 139 mM sucrose, 57.5 mM NaCl, and 0.75 mM CaCl 2 ). The tissue was then incubated in 5 mM CoCl 2 and 10 mM L-glutamic acid in the presence or absence of AMPA receptor blockers GYKI 52466 (40 M; Tocris) or IEM 13460 (100 M, Sigma) for 15 min. Co 2ϩ was precipitated with 0.24% ammonium sulfide, and the retina was then fixed in 0.8% glutaraldehyde and 20 m sections were prepared. Silver enhancement of the Co 2ϩ sulfide precipitate was performed using the Intense kit (GE Healthcare), then retinal sections were rinsed and mounted, and photomicrographs were captured with a Zeiss Axioplan 2 imaging microscope.
Statistical analyses
Statistical analyses were performed using one-way ANOVA, followed by nonparametric test (Tukey's multiple comparison test) or by Student's t test, as indicated in legends.
Results
NMDA induces NF-B-dependent death of retinal neurons
Retinal neurons, particularly amacrine and retinal ganglion cells, are exquisitely sensitive to excitotoxicity (Siliprandi et al., 1993; Kikuchi et al., 1995; Manabe and Lipton, 2003) . To dissect the signaling pathways that contribute to excitotoxic injury in the retina, we first established the time course of neuronal loss following NMDA intraocular injection. Two complementary techniques were used for quantification of neuronal cell death: TUNEL labeling on retinal cross sections, and Fluorogold retrograde labeling of retinal ganglion cells visualized on retinal whole mounts. Figure 1 A-C shows that TUNEL ϩ cells were first detected 3 h after NMDA exposure, and their number increased markedly by 6 and 24 h after NMDA injection. TUNEL staining was observed in the inner nuclear layer, in which amacrine cells are found, and in the ganglion cell layer, in which retinal ganglion cells and displaced amacrine cells are located. Fluorogold retrograde label-ing, performed to assess retinal ganglion cell viability, showed that NMDA injection resulted in rapid loss of these neurons: 50% of retinal ganglion cells remained at 6 h after NMDA exposure, while Ͻ10% survived at 24 h post-NMDA treatment ( Fig. 1 D, E) . Microglia and macrophages, which may have incorporated Fluorogold (Fluorochrome) after phagocytosis of dying retinal ganglion cells, were excluded based on morphological criteria. Microglia invariably have smaller cell size, visible process ramifications and lack axons (Thanos, 1991; Kacza and Seeger, 1997) (Fig. 1 D inset, arrowheads) . Although NMDA was administered in the dorsal (superior) retina, loss of Fluorogold-labeled retinal ganglion cells was similar between dorsal, ventral, nasal, and temporal retinal quadrants (ANOVA; p Ͼ 0.05; supplemental Fig. 1 , available at www.jneurosci.org as supplemental material). The apparent higher number of TUNEL ϩ cells compared with Fluorogold ϩ cells in the ganglion cell layer ( Fig. 1 A,D; 24 h) likely reflects that this layer is composed of retinal ganglion cells and displaced amacrine cells in ϳ1:1 ratio (Perry, 1981) . Therefore, TUNEL ϩ cells in the ganglion cell layer represent both retinal ganglion cells as well as displaced amacrine cells, whereas Fluorogold labels only retinal ganglion cells. NF-B transcriptional activity has been reported to promote proapoptotic or antiapoptotic responses following CNS injury (Maggirwar et al., 1998; Hamanoue et al., 1999; Schneider et al., 1999; Bhakar et al., 2002; Schwaninger et al., 2006) , but the molecular basis for these divergent effects remains unknown. To determine whether NF-B activity influenced NMDA-induced neuronal death in the retina, we asked whether SN50, a cell-permeable peptide that blocks nuclear translocation of NF-B subunits, altered levels of NMDA-induced cell loss. Intriguingly, coadministration of SN50 with NMDA sharply reduced the number of TUNEL ϩ cells, both in the ganglion cell layer and inner nuclear layer ( Fig. 2A) . In contrast, SN50M, a mutant form of SN50 that does not block NF-B nuclear translocation, had no effect on NMDA-induced TUNEL labeling.
Induction of canonical NF-B signaling requires activation of IB kinase (IKK)1 and IKK2, kinases that phosphorylate IB family members (Schmid and Birbach, 2008) . IKK2 often plays an obligatory role in canonical NF-B signaling; thus, we asked whether PS1145, a small-molecule inhibitor of IKK2, altered retinal ganglion cell death induced by NMDA. Figure 2 B shows that PS1145 elicited a remarkable inhibition of NMDA-induced retinal ganglion cell death, equivalent to that evoked by SN50 or by the noncompetitive NMDA receptor antagonist, MK801. Therefore, NF-B is strongly activated in the retina following NMDA exposure and inhibitors that block NF-B transcriptional activity, by different mechanisms, rescue neurons challenged with NMDA. We conclude that NF-B activation plays a crucial role in NMDA-induced loss of retinal neurons.
NMDA induces NF-B activity in Müller glia but not in retinal neurons
To determine the cellular localization of NMDA-induced NF-B activity in the adult retina, we used a well-characterized reporter mouse in which NF-B-responsive elements drive expression of nuclear ␤-gal (Bhakar et al., 2002) . In the PBS-treated, uninjured retina, almost no NF-B reporter activity was detected (Fig. 3A) . In contrast, retinas examined at 6, 18, and 24 h after NMDA injection showed a striking increase in ␤-gal activity within the inner nuclear layer (Fig. 3B-D) . The induction of NF-B in the retina invoked by NMDA was completely blocked by the NMDA receptor antagonist, MK-801 (Fig. 3E) , and with the NF-B inhibitor SN50 (Fig. 3F) . These results indicate that the ␤-gal activity detected in the inner nuclear layer reflects an NF-B transcriptional response mediated through activation of NMDA receptors.
The inner nuclear layer of the retina consists of interneurons (amacrine, bipolar, and horizontal cells) and Müller glial cells. To determine which of these cell types exhibit NMDA-induced NF-B activation, retina derived from NF-B reporter mice were stained using antibodies for ␤-gal and for retinal cell-type markers. After intravitreal injection of NMDA, ␤-gal-expressing cells were consistently positive for cellular retinaldehyde-binding protein (CRALBP), a specific Müller cell marker ( Fig. 4 A-C) . In contrast, ␤-gal staining was never found in cells positive for markers of bipolar and amacrine cells, including protein kinase C (Fig. 4 D-F ) or calretinin ( Fig. 4G-I ) , respectively. We conclude that Müller glia is the only cell type within the inner nuclear layer that undergoes NMDA-induced NF-B activation.
NMDA exposure induced ␤-gal expression in a very small number of cells within the ganglion cell layer in the NF-B reporter mice ( Fig. 3B-D) . In addition to retinal ganglion cells, this region contains astrocytes, macrophages, and displaced amacrine cells. The few ␤-gal-labeled cells observed in this region were invariably positive for cell-specific markers of astrocytes (GFAP, Fig. 4J -L) or macrophages (MAC-1, Fig. 4M-O) . ␤-gal staining was never observed in retinal ganglion cells retrogradely labeled with Fluorogold ( Fig.  4P -R) or in calretinin-positive displaced amacrine cells (data not shown). These data demonstrate that NMDA induces NF-B activity in Müller glia but not in retinal neurons. This finding led us to test the hypothesis that a Müller cell-derived factor, regulated by NF-B, acts in a non-cell-autonomous manner to facilitate neuronal death following NMDA exposure.
TNF␣ produced by Müller cells promotes NMDA-dependent neuronal loss
TNF␣ transcription is strongly regulated by NF-B activity (Shakhov et al., 1990; Hiscott et al., 1993; Mori and Prager, 1996) , and TNF␣ added exogenously can increase death of retinal neurons Nakazawa et al., 2006; Berger et al., 2008) . We therefore tested whether Müller cell-derived TNF␣ acts as an endogenous factor that facilitates NMDA-dependent neuronal death in vivo. Figure 5A shows that TNF␣ protein was undetectable in the adult, intact retina, but its levels increased dramatically after NMDA exposure. The NMDA-induced increase in TNF␣ expression was completely blocked by the NF-B inhibitor SN50, indicating that activation of NF-B plays a central role in NMDA-dependent expression of this cytokine. Similarly, TNF␣ was not detected in the uninjured retina by immunocytochemistry ( Fig. 5B ) but was clearly visualized after NMDA injection in presumptive Müller cell bodies and processes in the inner retina (Fig.  5C ). Moreover, NMDA-induced accumulation of TNF␣ immunoreactivity was blocked by the NF-B inhibitor SN50 (Fig.  5D) . Colabeling experiments using the Müller cell-specific marker CRALBP confirmed that Müller cells selectively upregulate expression of TNF␣ in the presence of NMDA ( Fig. 5E-G) . We conclude that Müller glial cells are the main cellular source of TNF␣ production in the retina following NMDA exposure.
To test whether Müller cell-derived TNF␣ facilitates excitotoxic death of retinal neurons, we examined whether the extent of NMDA-induced retinal ganglion cell loss was attenuated in the absence of TNF␣. Our data show striking survival of retinal ganglion cells in TNF␣ knock-out mice at 6 h after NMDA exposure: 76% of these neurons remained alive compared with only 42% in wild-type littermate controls ( p Ͻ 0.001) (Fig. 5H ). Although the total number of retinal ganglion cells in adult TNF␣ null mice treated only with vehicle was similar to that in wild-type mice (Fig. 5H) , it is conceivable that increased neuronal survival following NMDA injection in TNF␣ null mice reflects a chronic effect of TNF␣ deprivation. As an alternative approach, we blocked TNF␣ action in the retina using Etanercept, a soluble Fc fusion protein that contains the extracellular ligand-binding domain of TNF␣ receptor (TNFR)2 that is used clinically for blockade of TNF␣ in humans with rheumatoid arthritis or psoriasis (Fantuzzi et al., 2008; Lyudmila, 2008) . Figure 5H shows that Etanercept (Immunex), but not control Fc, protected retinal ganglion cells from NMDA-induced death. Etanercept protected 75% of these neurons from NMDAinduced death compared with only ϳ45% in Fc-treated or vehicle-treated controls ( p Ͻ 0.001). We conclude that TNF␣ derived from Müller glia acts in a non-cell-autonomous manner to promote NMDA-dependent neuronal death in the retina.
Endogenous TNF␣ exacerbates excitotoxicity by increasing neuronal Ca 2؉ -permeable AMPARs
We then asked what mechanisms are used by endogenous TNF␣ released from Müller cells to exacerbate NMDA-dependent neu-ronal loss in the retina. Engagement of the TNFR1 receptor can activate caspase-8 to induce apoptosis (Thorburn, 2004) . We therefore tested whether inhibition of caspase-8 activation reduced NMDA-mediated excitotoxicity. Blockade of caspase 8 activity using z-IETD-fmk, a potent caspase 8 inhibitor previously shown to effectively inhibit caspase 8 in vivo at the concentrations used here (Weishaupt et al., 2003) , had no effect on NMDA- induced retinal ganglion cell death (supplemental Fig. 2 , available at www.jneurosci.org as supplemental material). z-IETD-fmk, by itself, was not toxic and did not promote retinal ganglion cell death. These findings indicate that TNF␣-dependent neuronal loss occurs via an alternative pathway.
Exogenous TNF␣ has been shown to induce selective cell surface expression of Ca 2ϩ -permeable AMPARs (Beattie et al., 2002; Ogoshi et al., 2005; Stellwagen et al., 2005) , and their expression has been correlated with enhanced neuronal death in models of ischemia and excitotoxicity (Hermann et al., 2001; Noh et al., 2005; Ferguson et al., 2008; Leonoudakis et al., 2008) . We tested the hypothesis that TNF␣ produced by Müller glia increases cell surface Ca 2ϩ -permeable AMPARs on retinal neurons, thus rendering them more susceptible to excitotoxicity. Ca 2ϩ -permeable AMPARs transport divalent cations such as cobalt (Co 2ϩ ); therefore, we used an in situ Co 2ϩ staining technique to identify retinal cells that express Ca 2ϩ -permeable AMPARs. In the absence of NMDA, Co 2ϩ accumulation was restricted to cells in the inner nuclear and ganglion cell layers ( Fig.  6 A) previously identified as horizontal and AII amacrine cells (Osswald et al., 2007) as well as ganglion cells (Zhang et al., 1995) . Following NMDA exposure, both amacrine and retinal ganglion cells accumulated Co 2ϩ , indicating that Ca 2ϩ permeability in these cells was markedly enhanced when the retina was challenged with NMDA ( Fig. 6 B) . To test whether TNF␣ was required for NMDA-induced increase of Ca 2ϩ -permeable AMPARs on retinal neurons, NMDA was coadministered with the TNF␣ antagonist Etanercept. Figure 6C shows that Etanercept effectively diminished the NMDA-induced Co 2ϩ uptake.
To confirm that increased Co 2ϩ accumulation in retinal neurons occurs via Ca 2ϩ -permeable AMPARs and not other glutamate receptors, retinas were incubated with GYKI, a noncompetitive AMPAR-selective antagonist, and IEM, a channel blocker selective for Ca 2ϩpermeable non-NMDA receptors (i.e., AMPA and kainate receptors). Figure 6 , D and E, shows that NMDA-induced Co 2ϩ accumulation in these neurons was blocked with IEM and GYKI, indicating that NMDA-induced Co 2ϩ accumulation is due to increased flux of divalent cations exclusively through AMPARs. Finally, we tested whether TNF␣-mediated increase in neuronal Ca 2ϩ permeability influenced neuronal death following NMDA exposure. Figure 6 F shows that retinal ganglion cells were markedly protected from NMDA-induced death in the presence of either IEM (63% survival) or GYKI (76% survival) with respect to control retinas (ANOVA; p Ͻ 0.001). The neuronal survival afforded by AMPAR blockers was similar to that observed in TNF␣ null mice or following treatment with the TNF␣ antagonist Etanercept (Fig. 5H ). We conclude that Müller cell-derived TNF␣ plays a crucial role in the NMDA-dependent elaboration of Ca 2ϩpermeable AMPARs and, ultimately, excitotoxic death of retinal neurons.
Discussion
This study reports four major findings. First, NMDA exposure causes induction of NF-B activity in Müller glia, but not neurons, in the adult retina. Second, the death of amacrine and retinal ganglion cells induced by NMDA is sharply attenuated when Müller cell NF-B activation is blocked. Third, TNF␣ is the target of NF-B activity in Müller cells and is required for NMDAinduced loss of retinal neurons. Fourth, increased levels of Ca 2ϩ - permeable AMPARs evoked by Müller cell-derived TNF␣ is a crucial mechanism that renders retinal neurons susceptible to excitotoxic injury.
The accessibility and defined cellular architecture of the retina, together with the exquisite sensitivity of retinal neurons to NMDA, make it an ideal system to elucidate the contribution of NF-B to excitotoxicity. We showed that NF-B is activated in Müller glia following NMDA exposure. The effect of NMDA on NF-B activation in Müller glia was blocked by MK-801, confirming that NMDA receptors are involved in this response. NMDA receptors have been described on dissociated Müller cells from human (Puro et al., 1996) and chick retinas (Lamas et al., 2005) , and in situ hybridization studies have demonstrated expression of NMDA receptors in the rat inner plexiform layer where Müller cells reside Hartveit et al., 1994; Fletcher et al., 2000) . The functional properties of glial and neuronal NMDA receptors are thought to be different (Lamas et al., 2005) ; it is thus possible that NMDA receptors with different oligomeric structures differ in their ability to activate NF-B. Alternatively, NMDA-dependent NF-B activation in retinal glia may be indirect and results from a stimulating factor produced by neurons. Candidates for this effect are neuronal release of ATP and activation of glial P2Y receptors (Metea and Newman, 2006) and glutamate, which is released in high amounts by stressed neurons (Fujimoto et al., 2004) . Regarding the latter possibility, previous studies have shown that occupancy of metabotropic glutamate receptors on glia can induce NF-B activation (Caccamo et al., 2005a,b; Kaushal and Schlichter, 2008; Sitcheran et al., 2008) .
Blockade of NF-B activity in Mü ller cells dramatically reduced amacrine and retinal ganglion cell death, indicating that a Mü ller cell-derived factor plays a crucial role in NMDA-induced excitotoxicity. We focused on TNF␣ as a major effector in this pathway because the TNF␣ gene is tightly regulated by NF-B, and previous studies have indicated that TNF␣ can facilitate excitotoxic damage (Chao and Hu, 1994; Hermann et al., 2001; Bernardino et al., 2005; Noh et al., 2005; Ferguson et al., 2008; Kaushal and Schlichter, 2008; Leonoudakis et al., 2008) . We showed that TNF␣ in Mü ller glia was dramatically increased by NMDA exposure, and our loss of function experiments confirmed that TNF␣ plays an obligatory role in the loss of retinal neurons induced by NMDA. These results are consistent with a previous study showing that retinal ganglion cells lacking TNFR1 are protected following optic nerve crush (Tezel et al., 2004) . Interestingly, TNF␣ and TNFR1 have been shown to be upregulated in human donor eyes with glaucoma (Yan et al., 2000; Yuan and Neufeld, 2000; Tezel et al., 2001) , diabetic retinopathy, and age-related macular degeneration (Armstrong et al., 1998; Oh et al., 1999) ; in addition, TNF␣ gene polymorphisms have been found in patients with primary open angle glaucoma (Lin et al., 2003; Funayama et al., 2004) , supporting a crucial role for TNF␣ in ocular diseases.
How does NF-B-mediated production of TNF␣ by Müller glia kills retinal neurons? Ligand binding to TNFR1 triggers ap- optosis by induction of caspase-8 activation, which in turn activates caspase-3 and promotes cell death (Boldin et al., 1996; Hsu et al., 1996) . Previous studies have shown that TNF␣ released from microglia can kill primary cortical neurons via a caspase-8dependent mechanism (Velier et al., 1999; Kaushal and Schlichter, 2008) ; however, we found that caspase-8 inhibition had no effect on NMDA-induced apoptosis of retinal neurons in vivo. Nevertheless, apoptosis is still a major cell death mechanism in this model based on the widespread TUNEL labeling observed by us and others (Manabe and Lipton, 2003; Nakazawa et al., 2005) and is likely to involve induction of the intrinsic mitochondrial pathway and activation of caspase-3.
Our data support an alternative mechanism that invokes TNF␣-mediated increase of Ca 2ϩ -permeable AMPARs on neuronal cell surfaces. A series of elegant in vitro studies demonstrated that glia-derived TNF␣ selectively stimulates cell surface insertion of Ca 2ϩ -permeable AMPARs, while simultaneously decreasing surface GABA A receptors, a process required for rapid control of synaptic strength at excitatory synapses (Beattie et al., 2002; Stellwagen et al., 2005; Stellwagen and Malenka, 2006) . Ca 2ϩ -permeable AMPARs have been proposed as mediators of excitotoxic cell death (Kwak and Weiss, 2006; Liu and Zukin, 2007) . Recent studies have shown that exogenous TNF␣ may contribute to excitotoxicity by increasing cell surface levels of Ca 2ϩ -permeable AMPARs in primary hippocampal neurons and spinal cord (Ferguson et al., 2008; Leonoudakis et al., 2008) , but the cellular source and mechanisms that lead to TNF␣ production were not addressed in these studies. We provide the first in vivo evidence that Müller glia-derived TNF␣ exacerbates excitotoxic damage by increasing surface levels of Ca 2ϩ -permeable AMPARs in retinal neurons.
Our data support a model in which non-cell-autonomous signaling events play a major role in NMDA-triggered excitotoxicity in the retina. We demonstrate that NMDA-dependent activation of NF-B in Müller glial cells induces production of endogenous glia-derived TNF␣, which in turn renders retinal neurons highly sensitive to excitotoxicity by increasing their surface levels of Ca 2ϩ -permeable AMPARs. Our loss-of-function experiments show that this non-cell-autonomous mechanism accounts for Ͼ60% of the NMDA-induced neuronal loss in the retina. Given the prevalence of NMDA receptors on retinal neurons (Zhang and Diamond, 2006) , direct action of NMDA may play a modest, yet tangible, role in excitotoxicity in this system. However, our findings are a departure from the traditional paradigm of excitotoxic damage in which the death of neurons was entirely attributed to excessive Ca 2ϩ influx via neuronal NMDA receptors. Instead, our data indicate that glial regulation of neuronal AM-PAR distribution via TNF␣ is a central requirement for neuronal loss in retinal excitotoxicity.
There is strong evidence that glutamate, the endogenous neurotransmitter involved in excitotoxicity, increases intracellular Ca 2ϩ in retinal ganglion cells primarily via NMDA receptors (Hartwick et al., 2008) raising the question: how do AMPARs mediate neuronal death? Interestingly, AMPARs are highly permeable to Zn 2ϩ , whereas NMDA receptors are blocked by this cation. Zn 2ϩ , known to accumulate in hippocampal neurons following ischemia and before the onset of cell death (Koh et al., 1996; Lee et al., 2003) , is extremely toxic for neurons (Sensi et al., 1999 (Sensi et al., , 2003 Jiang et al., 2001; Kim and Koh, 2002) . The elucidation of the precise role of Zn 2ϩ in retinal ganglion cell death will be an interesting topic for future studies.
Our results are unexpected because Müller cells have been traditionally attributed a neuroprotective role under physiologi-cal conditions (Bringmann et al., 2006) . Indeed, one of the normal functions of Müller cells is the modulation of synaptic transmission and neuronal excitability in the mammalian retina (Newman, 2004) . It is possible that the injury-induced effects reported here represent the end of a physiological continuum; it will be interesting to determine if the low levels of TNF␣ produced by Müller cells in the uninjured, adult retina alters synaptic transmission through AMPAR-dependent mechanisms.
The failure of NMDA receptor antagonists in clinical trials (Lee et al., 1999; Ikonomidou and Turski, 2002; Kemp and McKernan, 2002; Kalia et al., 2008) presupposes that other molecular mechanisms play a critical role following the initial excitotoxic insult. Our study provides new insight into these events in vivo by demonstrating a new role for NF-B in the injured CNS. Furthermore, we identify TNF␣ as a key glial-to-neuron signal that exacerbates excitotoxicity through modulation of Ca 2ϩ -permeable AMPARs. The precise delineation of the molecular events that occur in glia versus those in neurons, as shown here, should be useful for the design of novel therapeutic interventions applicable to neurodegenerative diseases and ischemia.
